To Sell Subsidiary Mitsubishi Tanabe Pharma To Bain Capital For About 510 Billion Yen
07/02/2025 07:02
Feb 7 (Reuters) - Mitsubishi Chemical Group Corp
4188.T :
* MITSUBISHI CHEMICAL GROUP: TO SELL SUBSIDIARY MITSUBISHI
TANABE
PHARMA TO BAIN CAPITAL FOR ABOUT 510 BILLION YEN
* MITSUBISHI CHEMICAL GROUP: TO BOOK ABOUT 95 BILLION YEN
GAINS
RELATED TO SALE OF MITSUBISHI TANABE PHARMA IN Q2 FY2025/26
Source text: ID:
Further company coverage: 4188.T
Recent news on Mitsubishi Chemical
See all newsJapan state-backed fund considering sale of chipmaking materials maker JSR, sources say
Japan state-backed fund considering sale of chipmaking materials maker JSR, sources say
Brief: Mitsubishi Chemical Group Corp - Notice Regarding Commencement Of Consideration On Spin-Off Of Petrochemicals Business As A Wholly Owned Subsidiary
Bain-backed Tanabe Pharma targets three new drug launches a year in Japan
2025/26 group results (IFRS)